XNAS: MNPR
Monopar Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company developing a treatment for Wilson disease and novel radiopharmaceuticals for oncology. Its Wilson disease product candidate is ALXN1840, a late-stage, investigational once-daily, ...
Read More
57.70
-0.21
(-0.36%)
259.9K
XNAS Volume
XNAS 16 Apr, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Monopar Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..